Integrative Omics for Informed Drug Repurposing: Targeting CNS Disorders
Rammohan Shukla, Nicholas Henkel, Khaled Alganem, Abdul-Rizaq Ali Hamoud, James K. Reigle, Rawan S. Alnafisah, Hunter Eby, Ali Sajid Imami, Justin F. Creeden, Scott A. Miruzzi, Jarek Meller, Robert Erne McCullumsmith
This paper reviews signature-based in silico approaches for drug repurposing in CNS disorders, integrating data science platforms to improve clinical relevance and address regulatory and knowledge challenges.
bioRxiv · Apr 24, 2020 · PreprintNeuroscience